NANOBIOTIX S.A. SP.ADR Cash Flow-to-Debt Ratio
NANOBIOTIX S.A. SP.ADR cash flow-to-debt ratio. NANOBIOTIX S.A. SP.ADR (5NRA) has a Cash Flow-to-Debt Ratio of -0.22x as of December 2025, meaning its operating cash flow of €-33.42 Million could theoretically repay 0% of its total liabilities (€152.24 Million) in one year. See NANOBIOTIX S.A. SP.ADR free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of NANOBIOTIX S.A. SP.ADR (2021–2025)
Cash flow-to-debt ratio of NANOBIOTIX S.A. SP.ADR from 2021 to 2025. Historical debt coverage capacity for NANOBIOTIX S.A. SP.ADR across 5 annual periods. Also explore net asset growth rate of NANOBIOTIX S.A. SP.ADR to track the company's year-over-year net asset growth rate.
NANOBIOTIX S.A. SP.ADR Cash Flow-to-Debt Ratio by Year (2021–2025)
NANOBIOTIX S.A. SP.ADR cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for NANOBIOTIX S.A. SP.ADR. For the full cash flow conversion analysis, see NANOBIOTIX S.A. SP.ADR (5NRA) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.22x | €-33.42 Million | €152.24 Million | ▼ -49.5% |
| 2024 | -0.15x | €-19.55 Million | €133.12 Million | ▼ -12.7% |
| 2023 | -0.13x | €-12.48 Million | €95.74 Million | ▲ +69.5% |
| 2022 | -0.43x | €-37.10 Million | €86.81 Million | ▼ -7.3% |
| 2021 | -0.40x | €-29.87 Million | €74.98 Million | — |